COMPUTE HEALTH ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On January 29, 2023, Dr. Osama Alswailem, an independent member of the Board of Directors (the "Board") of Compute Health Acquisition Corp. (the "Company"), notified the Board of his resignation as a member of the Board, effective as of January 29, 2023.

On January 31, 2023, the Company notified the New York Stock Exchange (the "NYSE") that, after giving effect to Dr. Alswailem's resignation, the Company no longer had a majority of independent directors as required by Section 303A.01 of the NYSE Listed Company Manual.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 29, 2023, Dr. Alswailem notified the Board of his resignation as a member of the Board, effective as of January 29, 2023.

To cause the Company to satisfy the NYSE requirement that it have a majority of independent directors, on January 31, 2023, Dr. Jean Nehmé notified the Board of his resignation as a member of the Board, effective as of January 31, 2023.

Dr. Nehmé will continue to serve in his position as Co-Chief Executive Officer of the Company following his resignation as a member of the Board.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit
  No.                                   Description
104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)




                                       1

© Edgar Online, source Glimpses